Menu
Close
Stories & News
Resources
Stay Informed
x
Stay Informed
March 14, 2022
Pfizer paid its first quarter dividend on the company’s common stock in March, the company’s 333rd consecutive quarterly dividend. The cash payment to shareholders represents the 12th year of dividend increases.
“The increase in dividend is a direct reflection of our strong financial performance and continued confidence in our current product portfolio and R&D pipeline,” said Dr. Albert Bourla, Pfizer Chairman and Chief Executive Officer.
Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.
Copyright © 2002 – 2025 Pfizer Investor Insights All rights reserved. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries. This website contains certain information about Pfizer, but may not contain all information that is material to Pfizer.